COVID‐19, myocarditis, and the other side of the bed
Emer Joyce speaks about the impact COVID-19 has had on the clinical landscape of acute cardiac, intensive care and cardiomyopathy/heart failure services including the wide spectrum…
View More COVID‐19, myocarditis, and the other side of the bed
BSH position statement on the roll out of COVID-19 vaccinations
Read the BSH position statement on the roll out of COVID-19 vaccinations The BSH has recently released a statement regarding COVID-19 vaccinations. The statement advises:…
View More BSH position statement on the roll out of COVID-19 vaccinations
Possible inhibition of ICD therapies by newer generation iPhone 12
The Heart Rhythm Society recently published information regarding an important public health issue concerning the newer generation iPhone 12 which can potentially inhibit lifesaving therapy…
View More Possible inhibition of ICD therapies by newer generation iPhone 12
BCS Review of ESC Clinical Practice Guidelines: 2020
In 2020, new clinical practice guidelines were published by the European Society of Cardiology. The BCS Clinical Standards Group has reviewed the guidelines and written…
View More BCS Review of ESC Clinical Practice Guidelines: 2020
Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…
View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban
Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients
Dr Amit Bhan examines a study on Novel Oral Anticoagulants recently published in the European Heart Journal.
View More Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients
The Expanding Role of Social Media in Cardiovascular Work
The following two articles explore the roles social media can play in the cardiovascular sector. From research, to peer-to-peer engagement to recruitment. Social media in…
View More The Expanding Role of Social Media in Cardiovascular Work
PHE publishes updated Cardiovascular Disease Profiles
Public Health England (PHE) has recently published data analysis on cardiovascular disease and cardiovascular related conditions of heart disease, stroke, diabetes and kidney disease. The…
View More PHE publishes updated Cardiovascular Disease Profiles
CaReMe Heart Failure in Adults: Diagnosis & Management Algorithm
CaReMe has today released the Heart Failure Management Algorithm Modified from: Management algorithm for NICE Guideline “Chronic Heart Failure in Adults: diagnosis & management” https://www.nice.org.uk/guidance/ng106…
View More CaReMe Heart Failure in Adults: Diagnosis & Management Algorithm
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
Important data from Brazil demonstrating the safety and non inferiority of DOAC therapy in biological mitral valves and atrial fibrillation. This study makes a significant…
View More Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve